Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets (Unaudited)

v3.22.2.2
Condensed Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 96,779 $ 30,414
Marketable securities 190,560 130,343
Investment in equity securities 36,909 37,181
Accounts receivable 11,241 12,454
Prepaid expenses and other current assets 11,064 8,123
Total current assets 346,553 218,515
Property and equipment, net 24,281 22,550
Operating lease right-of-use assets 27,073 29,041
Marketable securities, non-current 0 68,775
Other non-current assets 1,921 1,655
Restricted cash 872 872
Total assets 400,700 341,408
Current liabilities:    
Accounts payable 12,443 11,327
Accrued compensation 10,380 11,417
Deferred revenue—current 15,920 5,496
Operating lease liability - current 2,631 1,037
Debt—current 12,500 9,375
Other current liabilities 4,414 3,084
Total current liabilities 58,288 41,736
Deferred revenue - non-current 74,732  
Operating lease liability - non-current 31,038 31,224
Debt—non-current 6,783 15,738
Other non-current liabilities 133 146
Total liabilities 170,974 88,844
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Preferred stock, $0.001 par value - 10,000,000 shares authorized as of September 30, 2022 and December 31, 2021; 0 shares issued and outstanding as of September 30, 2022 and December 31, 2021
Common stock, $0.001 par value - 300,000,000 shares authorized as of September 30, 2022 and December 31, 2021; 54,631,360 and46,327,131 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively 55 46
Additional paid-in-capital 649,028 586,243
Accumulated other comprehensive (loss) income (1,336) (314)
Accumulated deficit (418,021) (333,411)
Total stockholders’ equity 229,726 252,564
Total Liabilities and Stockholders’ Equity $ 400,700 $ 341,408